Atrial Natriuretic Peptide and Parathyroid Hormone (1–84) in Relation to Noradrenaline Induced Changes in Blood Pressure in Uraemic and Healthy Subjects

REFERENCES

• Aalkjær C, Pedersen EB, Danielsen H, Fjeldborg O, Jespersen B, Kjær T, Sørensen SS, Mulvany MJ. Morphological and functional characteristics of isolated resistance vessels in advanced uraemia. Clin Sci 1986; 71: 657–663.
   Web of Science ®Google Scholar
• Beretta-Piccoli C, Weidmann P, Schiffl H, Cottier C, Reubi FC. Enhanced cardiovascular pressor reactivity to noradrenaline in mild renal parenchymal disease. Kidney Int 1982; 22: 297–303.
   PubMed Web of Science ®Google Scholar
• Campese VM. Calcium, parathyroid hormone, and blood pressure. Am J Hypertens 1989; 2: 34S–44S.
   PubMed Web of Science ®Google Scholar
• Campese VM, Romoff MS, Levitan D, Lane K, Massry SG. Mechanisms of autonomic nervous system dysfunction in uremia. Kidney Int 1981; 20: 246–253.
   PubMed Web of Science ®Google Scholar
• Christensen G, Ilebekk A, Aksnes G, Kill F. Effect of adrenergic stimulation on release of atrial natriuretic factor (ANF). XIth international congress of nephrology, Japan 1990: 267A.
   Google Scholar
• Collins J, Massry SG, Campese VM. Parathyroid hormone and the altered vascular response to norepinephrine in uremia. Am J Nephrol 1985; 5: 110–113.
   PubMed Web of Science ®Google Scholar
• Currie MG, Newman WH. Evidence for alfa-1 adrenergic receptor regulation of atriopeptin release from the isolated rat heart. Biochem Biophys Res Commun 1986; 137: 94–100.
   PubMed Web of Science ®Google Scholar
• Fisher JA, Blum JW. Noncalcium control of parathyroid hormone secretion. Min Electr Metab 1980; 3: 158–166.
   Google Scholar
• Greenberg SS, Cantor E, Diecke FPJ, Peevy K, Tanaka TP. Cyclic GMP modulates release of norepinephrine from adrenergic nerves innervating canine arteries. Am J Hypertens 1991; 4: 173–176.
   PubMed Web of Science ®Google Scholar
• Guerin AP, London GM, Marchais SJ, Metivier F, Safar ME, Sassano P. Parathyroid hormone and cardiovascular effects of dihydropyridines in chronic renal failure. Am J Hypertens 1990; 3: 566–569.
   PubMed Web of Science ®Google Scholar
• Haass M, Zukowska-Grojec Z, Kopin IJ, Zamir N. Role of autonomic nervous system and vasoactive hormones in the release of atrial natriuretic peptides in conscious rats. J Cardiovasc Pharmacol 1987; 10: 424–432.
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Matsushita Y, Inoue T, Morii H, Ishibashi M, Yamaji T. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure. J Clin Endocrinol Metab 1986; 63: 819–822.
   PubMed Web of Science ®Google Scholar
• Hollander M, Wolfe DA. Nonparametric statistical methods. New York: Wiley, 1973.
   Google Scholar
• Hollister AS, Rodeheffer RJ, White FJ, Potts JR, Imada T, Inagami T. Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog. J Clin Invest 1989; 83: 623–628.
   PubMed Web of Science ®Google Scholar
• Iseki K. Parathyroid hormone and the vascular response to norepinephrine. Am J Hypertens 1990; 3: 238S–240S.
   PubMed Web of Science ®Google Scholar
• Jespersen B, Eiskjær H, Pedersen EB. Effect of atrial natriuretic peptide on blood pressure, guanosine 3':5'-cyclic monophosphate release and blood volume in uraemic patients. Clin Sci 1990; 78: 67–73.
   Web of Science ®Google Scholar
• Jespersen B, Pedersen EB. Increased plasma levels of atrial natriuretic peptide in patients with chronic renal failure: Effect of noradrenaline infusion. Nephrol Dial Transplant 1988; 3: 762–767.
   PubMed Web of Science ®Google Scholar
• Lang RE, Unger T, Gantan D. Atrial natriuretic peptide: a new factor in blood pressure control. J Hypertension 1987; 5: 255–271.
   PubMed Web of Science ®Google Scholar
• Muther RS, Reid GM, Benne WM. Management of hypertension in the patient with renal insufficiency or renal failure. The kidney in hypertension. New York: Raven Press, 1987: 251–268.
   Google Scholar
• Nussbaum SR, Zahradnik RJ, Lavigne JR et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcaemia. Clin Chem 1987; 33: 1364–1367.
   PubMed Web of Science ®Google Scholar
• Pruszczynski W, Viron B, Czekalski S, Mignon F, Ardaillou R. Role of cardiac parasympathetic dysfunction in atrial natriuretic peptide response to volume changes in patients with chronic renal failure. Min Elect Metab 1987; 13: 333–339.
   PubMedGoogle Scholar
• Schiebinger RJ, Baker MZ, Linden J. Effect of adrenergic and muscarinic cholinergic agonists on atrial natriuretic peptide secretion by isolated rat atria. Potential role of the autonomic nervous system in modulating atrial natriuretic peptide secretion. J Clin Invest 1987; 80: 1687–1691.
   PubMed Web of Science ®Google Scholar
• Shimamoto K, Nakagawa M, Fukuyama S, Ura N, Murakami H, Yonekura S, Iwakura M, Yamaguchi Y, Ise T, Saitoh S, Sakakibara T, Satoh S, Matsuda K, Iimura O. Effects of norepinephrine and angiotensin II on plasma atrial natriuretic peptide concentration in humans. J Cardiovasc Pharmacol 1989; 13 (Suppl 6): 59–62.
   Google Scholar
• Thomassen AR, Bagger JP, Nielsen TT, Pedersen EB. Atrial natriuretic peptide during pacing in controls and patients with coronary arterial disease. Int J Cardiol 1987; 17: 267–276.
   PubMed Web of Science ®Google Scholar
• Tonolo G, McMillan M, Polonia J, Pazzola A, Montorsi P, Soro A, Glorioso N, Richards MA. Plasma clearance and effects of alfa-hANP infused in patients with end-stage renal failure. Am J Physiol 1988; 254: F895–899.
   PubMedGoogle Scholar
• Tsutamoto T, Bito K, Kinoshita M. Plasma atrial natriuretic polypeptide as an index of left ventricular end-diastolic pressure in patients with chronic left-sided heart failure. Am Heart J 1989; 117: 599–606.
   PubMed Web of Science ®Google Scholar
• Uehlinger DE, Zaman T, Weidmann P, Shaw S, Gnädinger MP. Pressure dependence of atrial natriuretic peptide during norepinephrine infusion in humans. Hypertension 1987; 10: 249–253.
   PubMed Web of Science ®Google Scholar
• Uehlinger DE, Weidmann P, Gnaedinger MP, Shaw S, Lang RE. Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man. J Clin Endocrinol Metab 1986; 63: 669–674.
   PubMed Web of Science ®Google Scholar
• Walker RG, Swainson CP, Yandle TG, Nicholls MG, Espiner EA. Exaggerated responsiveness of immunoreactive atrial natriuretic peptide to salin infusion in chronic renal failure. Clin Sci 1987; 72: 19–24.
   PubMed Web of Science ®Google Scholar
• Weidmann P. Pathogenesis of hypertension associated with chronic renal failure. Contr Nephrol 1984; 41: 47–65.
   PubMedGoogle Scholar
• Wilkins MR, Wood JA, Adu D, Lote CJ, Kendall MJ, Michael J. Change in plasma immunoreactive atrial natriuretic peptide during sequential ultrafiltration and haemodialysis. Clin Sci 1986; 71: 157–160.
   Web of Science ®Google Scholar
• Yasujima M, Abe K, Kohzuki M, Tanno M, Kasai Y, Sato M, Omata K, Kudo K, Tsunoda K, Takeuchi K, Yoshinaga K, Inagami T. Atrial natriuretic factor inhibits the hypertension induced by chronic infusion of norepinephrine in conscious rats. Circ Res 1985; 57: 470–474.
   PubMed Web of Science ®Google Scholar